Recursion Pharmaceuticals (RXRX) Tax Provisions (2023 - 2026)
Recursion Pharmaceuticals (RXRX) posted Tax Provisions of -$4.6 million for Q1 2026, down 23120.0% on a QoQ basis from $20000.0 in Q4 2025, and down 2813.92% year-over-year from $169643.7 in Q1 2025.
Recursion Pharmaceuticals (RXRX) Tax Provisions (2023 - 2026) Analysis & Trends
Recursion Pharmaceuticals' Tax Provisions history runs 4 years deep, the most recent figure standing at -$4.6 million for Q1 2026.
- Quarterly Tax Provisions fell 2813.92% year-over-year to -$4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.6 million (down 803.55% YoY) and the FY2025 annual result came in at -$136000.0, up 87.93% from the prior year.
- Tax Provisions was -$4.6 million for Q1 2026 at Recursion Pharmaceuticals, down from $20000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $167000.0 in Q3 2024 and bottomed at -$4.6 million in Q1 2026.
- A 4-year average of -$1.1 million and a median of -$158000.0 in 2025 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2025 — Tax Provisions surged 185.71% — and 2026, when it slumped 2813.92%.
- Recursion Pharmaceuticals' Tax Provisions stood at -$4.1 million in 2023, then jumped by 100.17% to $7000.0 in 2024, then jumped by 185.71% to $20000.0 in 2025, then slumped by 23120.0% to -$4.6 million in 2026.
- Business Quant data shows RXRX's Tax Provisions at -$4.6 million in Q1 2026, $20000.0 in Q4 2025, and $3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.57 Bn | 912.05 Mn | -6.02 Mn | -4.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.60 Mn |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Mar 31, 2025 | -158,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 167,000.00 |
| Jun 30, 2024 | -523,000.00 |
| Mar 31, 2024 | -779,000.00 |
| Dec 31, 2023 | -4.06 Mn |